Temporal trends in treatment of ST segment elevation myocardial infarction in Switzerland from 1997 to 2005;Evolution du traitement de reperfusion de l'infarctus du myocarde avec sus-décalage du segment ST en Suisse de 1997 à 2005

Revue Medicale Suisse

Volumn 2, Issue 67, 2006, Pages 1393-1398

  Fassa, Amir Ali ^a   Urban, Philip ^c   Radovanovic, Dragana ^d   Duvoisin, Nicole ^d   Gaspoz, Jean Michel ^b   Stauffer, Jean Christophe ^e   Erne, Paul ^f  

^a Service de Cardiologie   (Switzerland)

^b SERVICE DE MÉDECINE INTERNE GÉNÉRALE   (Switzerland)

^c LA TOUR HOSPITAL   (Switzerland)

^d UNIVERSITY OF ZURICH   (Switzerland)

^e LAUSANNE UNIVERSITY HOSPITAL   (Switzerland)

^f LUZERNER KANTONSSPITAL   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

FIBRINOLYTIC AGENT;

ACUTE CORONARY SYNDROME; BLOOD CLOT LYSIS; CARDIOGENIC SHOCK; ELECTROCARDIOGRAM; HEART INFARCTION; HEART LEFT BUNDLE BRANCH BLOCK; HEART VENTRICLE ARRHYTHMIA; HEART VENTRICLE FIBRILLATION; HOSPITAL ADMISSION; HUMAN; MORTALITY; PERCUTANEOUS CORONARY INTERVENTION; PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY; REGISTER; REPERFUSION; REVIEW; ST SEGMENT ELEVATION; SWITZERLAND; ARTICLE; ELECTROCARDIOGRAPHY; FEMALE; FIBRINOLYTIC THERAPY; HEART MUSCLE REPERFUSION; MALE; MIDDLE AGED; STATISTICS; TRANSLUMINAL CORONARY ANGIOPLASTY;

ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY; ELECTROCARDIOGRAPHY; FEMALE; HOSPITAL MORTALITY; HUMANS; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; MYOCARDIAL REPERFUSION; REGISTRIES; SWITZERLAND; THROMBOLYTIC THERAPY;

EID: 33746649763     PISSN: 16609379     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (19)

1. GISSI Investigators. Gruppo Italiano per lo Studio delta Streptochinasi nell'Infarto Miocardico (GISSI). Effectiveness of intravenous thrombotytic treatment in acute myocardial infarction. Lancet 1986;1:397-402.
2. ISIS-2 Collaborative Group. Randomised trial of intravenous streptokinase, oral aspirin, both, or neither among 17187 cases of suspected acute myocardial infarction: ISIS-2, Lancet 1988;2:349-60.
3. ** Keeley EC, Boura JA, Grines CL. Primary angioplasty versus intravenous thrombolytic therapy for acute myocardial infarction: A quantitative review of 23 randomised trials. Lancet 2003;361:13-20.
4. Antman EM, Anbe DT, Armstrong PW, et al. ACC/AHA guidelines for the management of patients with ST-elevation myocardial infarction-executive summary. A report of the American college of cardiology/American heart association task force on practice guidelines (Writing Committee to revise the 1999 guidelines for the management of patients with acute myocardial infarction). J Am Coll Cardiol 2004;44:671-719.
5. Van de Werf F, Ardissino D, Betriu A, et al. Management of acute myocardial infarction in patients presenting with ST-segment elevation. The task force on the management of acute myocardial infarction of the european society of cardiology. Eur Heart J 2003;24:28-66.
6. Zahn R, Schiele R, Schneider S. for the Maximal individual therapy in acute myocardial infarction (MITRA) and the Myocardial infarction registry (MIR) study groups, et al. Decreasing hospital mortality between 1994 and 1998 in patients with acute myocardial infarction treated with primary angioplasty but not in patients treated with intravenous thrombotysis. Results from the pooled data of the maximal individual therapy in acute myocardial infarction (MITRA) registry and the myocardial infarction registry (MIR). J Am Coll Cardiol 2000;36: 2064-71.
7. Rogers WJ, Canto JG, Lambrew CT, et al, for the Investigators in the national registry of myocardial infarction 1,2 and 3. Temporal trends in the treatment of over 1,5 million patients with myocardial infarction in the US from 1990 through 1999. The national registry of myocardial infarction 1, 2 and 3. J Am Coll Cardiol 2000; 36:2056-63.
8. * Fox KAA, Goodman SG, Anderson FA, on behalf of the GRACE Investigators, et al. From guidelines to clinical practice: The impact of hospital and geographical characteristics on temporal trends in the management of acute coronary syndromes. The global registry of acute coronary events (GRACE). Eur Heart J 2003;24: 1414-24.
9. Fox KAA, Cokkinos DV, Deckers J, on behalf of the ENACT (European network for acute coronary treatment) investigators, et al. The ENACT study: A pan-European survey of acute coronary syndromes. Eur Heart J 2000;21:1440-9.
10. * Hasdai D, Behar S, Wallentin L, et al. A prospective survey of the characteristics, treatments and outcomes of patients with acute coronary syndromes in Europe and the Mediterranean basin. The Euro heart survey of acute coronary syndromes (Euro heart survey ACS). Eur Heart J 2002;23:1190-201.
11. * Fassa AA, Urban P, Radovanovic D, et al. Trends in reperfusion therapy of ST segment elevation myocardial infarction in Switzerland: Six year results from a nationwide registry. Heart 2005;91:882-8.
12. www.amis-plus.ch
13. Fibrinolytic Therapy Trialists' (FTT) Collaborative Group. Indications for fibrinolytic therapy in suspected acute myocardial infarction: Collaborative overview of early mortality and major morbidity results from all randomised trials of more than 1000 patients. Lancet 1994;343:311-21
14. * Andersen HR, Nielsen TT, Rasmussen K, et al. A comparison of coronary angioplasty with fibrinolytic therapy in acute myocardial infarction. N Engl J Med 2003;349:733-41
15. Schlüter L, Rickli H, Vuillomet A, et al. Interventions cardiaques percutanées en Suisse en 2001. Kardiovaskuläre Medizin 2004;7:61-70.
16. Meyer P, Barragan P, Blanchard D, et al. Recommandations de la Société française de cardiologie concernant la formation des médecins coronographistes et angioplasticiens, l'organisation et l'équipement des centres de coronographie et d'angioplastie coronaire. Arch Mal Coeur 2000;93:147-58.
17. Campbell RW, Murray A, Julian DG. Ventricular arrhythmias in first 12 hours of acute myocardial infarction. Natural history study. Br Heart J 1981;46:351-7.
18. * Gaspoz JM, Unger PF, Urban P, et al. Impact of a public campaign on prehospital delay in patients reporting chest pain. Heart 1996;76:150-5.
19. Bassand JP, Danchin N, Filippatos G, et al. Implementation of reperfusion therapy in acute myocardial infarction. A policy statement from the European Society of Cardiology. Eur Heart J 2005;26:2733-41.